Shivang Doshi currently serves as the Vice President of Global Payor Relations and Reimbursement at Paige, where he is focused on clinical and economic evidence generation, payor engagement and implementing pathways to drive payor coverage and reimbursement for AI-based diagnostics. Shivang has over 10 years of experiences in the life sciences industry developing global commercialization and market access strategies for numerous diagnostic technologies, including NGS, liquid biopsy, gene expression profiling, companion diagnostics and digital pathology. Previously, Shivang served as the VP of Precision Medicine at Boston Healthcare Associates (now part of Veranex) and conducted drug discovery research at Novartis.
AI/ML-related healthcare products/services have begun changing the healthcare landscape. Watershed events in AI diagnostics include recent FDA approvals in imaging and data integration and guidance for Software as a Medical Device. What role will AI/ML play and what should criteria be for reimbursement as healthcare pivots to value-base models?